Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sanofi
  6. News
  7. Summary
    SAN   FR0000120578

SANOFI

(SAN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sanofi : Commits $52 Million, Other Guarantees For British Pension Scheme

06/16/2021 | 01:19am EDT


ę MT Newswires 2021
All news about SANOFI
07/23PRESS RELEASE : Pfizer And BioNTech to Supply U.S. -2-
DJ
07/22SANOFI : continues streamlining of established products with sale of dental care..
PU
07/21GLOBAL MARKETS LIVE : Netflix, Novartis, Tesla, Autodesk, AMC...
07/21European ADRs Move Sharply Higher in Wednesday Trading
MT
07/21PRESS RELEASE : Pfizer and BioNTech Announce -3-
DJ
07/20SANOFI : GSK COVID-19 Vaccine Candidate Enters Real-Time Review in EU
MT
07/20Agilent Technologies PharmDx Assay Receives Expanded Use in EU
MT
07/20EU begins real-time review of Sanofi-GSK COVID-19 vaccine
RE
07/20EU Drug Agency Begins Rolling Review of Sanofi Covid-19 Vaccine Candidate
DJ
07/20SANOFI : - US FDA approves fexinidazole as the first all-oral treatment for slee..
AQ
More news
Financials
Sales 2021 36 920 M 43 484 M 43 484 M
Net income 2021 5 946 M 7 003 M 7 003 M
Net Debt 2021 6 959 M 8 196 M 8 196 M
P/E ratio 2021 18,5x
Yield 2021 3,72%
Capitalization 110 B 130 B 130 B
EV / Sales 2021 3,17x
EV / Sales 2022 2,93x
Nbr of Employees 99 412
Free-Float 88,3%
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 88,07 €
Average target price 102,63 €
Spread / Average Target 16,5%
EPS Revisions
Managers and Directors
Paul Hudson Chief Executive Officer & Director
Jean-Baptiste Chasseloup de Chatillon Chief Financial Officer & Executive Vice President
Serge Weinberg Chairman
John C. Reed EVP & Global Head-Research & Development
Nestle Frank Global Head-Immunology Therapeutic Research Area
Sector and Competitors
1st jan.Capi. (M$)
SANOFI11.91%131 827
JOHNSON & JOHNSON9.16%432 430
ROCHE HOLDING AG12.39%325 975
PFIZER, INC.13.23%218 198
ELI LILLY AND COMPANY44.60%209 276
NOVARTIS AG1.10%207 246